However, the group with PTH-SC ≤1 pmol/L would need closer monitoring because even though 5/19 or 26.3 % never developed clinically relevant hypocalcemia, the other 14 required some oral calcium and/or calcitriol supplements to maintain normocalcemia. This evidence concerns the gene PTH and Hypocalcemia.